C. Prouty

发表

A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group.

Russell L. Stogsdill, Daniel T. Halstead, William C. Paganelli, 1996, JAMA.

Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.

D. Hoyer, T. Graybill, C. Prouty, 1997, Journal of medicinal chemistry.

Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.

S. Emanuel, P. Connolly, L. Jolliffe, 2003, Journal of medicinal chemistry.

α-((Tetronoyl)oxy)- and α-((tetramoyl)oxy)methyl ketone inhibitors of the interleukin-1β converting enzyme (ICE)

T. Graybill, C. Prouty, R. Dolle, 1997 .

Oligosaccharide Portion of GM1 Enhances Process Formation by S20Y Neuroblastoma Cells

C. Schengrund, C. Prouty, 1988, Journal of neurochemistry.

Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.

S. Emanuel, R. H. Gruninger, Angel R. Fuentes-Pesquera, 2005, Journal of medicinal chemistry.

Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors.

C. Prouty, G. Kuo, W. Murray, 2010, Bioorganic & medicinal chemistry letters.

First Examples of Peptidomimetic Inhibitors of Interleukin-1β Converting Enzyme

A. Saha, C. Prouty, J. Salvino, 1996 .

Achiral internucleoside linkages : CH2-CH2-NH and NH-CH2-CH2 linkages

T. Caulfield, A. Saha, C. Prouty, 1993 .

Achiral internucleoside linkages 3: CH2NHCH2 linkage

T. Caulfield, A. Saha, C. Prouty, 1995 .

Achiral internucleoside linkages 2: O-CH2-CH2 linkage

T. Caulfield, A. Saha, C. Prouty, 1994 .

Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.

M. Williams, E. Bacon, C. Prouty, 2011, Journal of medicinal chemistry.

Design, synthesis and biological evaluation of pyridine-phenylpiperazines: a novel series of potent and selective alpha1a-adrenergic receptor antagonist.

L. Jolliffe, C. Prouty, V. Pulito, 2000, Bioorganic & medicinal chemistry.

Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.

L. Jolliffe, C. Prouty, V. Pulito, 2000, Journal of medicinal chemistry.

Structural and stereochemical requirements of time-dependent inactivators of the interleukin-1β converting enzyme

Robert E. Miller, T. Graybill, C. Prouty, 1995 .

Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3 beta (GSK-3 beta) inhibitors.

Xin Chen, C. Prouty, M. P. Beavers, 2004, Bioorganic & Medicinal Chemistry.

Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3β (GSK-3β) inhibitors☆

Xin Chen, C. Prouty, M. P. Beavers, 2004 .